|
ZNF226 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.44599999999329E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.194500E-04 |
| Normal-vs-Stage2 |
5.318300E-02 |
| Normal-vs-Stage3 |
3.53829999999444E-06 |
| Normal-vs-Stage4 |
3.66550000019394E-07 |
| Stage1-vs-Stage2 |
4.838600E-01 |
| Stage1-vs-Stage3 |
1.236440E-01 |
| Stage1-vs-Stage4 |
2.264000E-02 |
| Stage2-vs-Stage3 |
1.242570E-01 |
| Stage2-vs-Stage4 |
2.471800E-02 |
| Stage3-vs-Stage4 |
2.566000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.68750000000473E-05 |
| Normal-vs-AfricanAmerican |
1.557710E-02 |
| Normal-vs-Asian |
1.196200E-03 |
| Caucasian-vs-AfricanAmerican |
7.797200E-01 |
| Caucasian-vs-Asian |
9.858200E-01 |
| AfricanAmerican-vs-Asian |
7.844000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.433300E-04 |
| Normal-vs-Female |
7.98120000000679E-05 |
| Male-vs-Female |
7.766800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.234900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.979400E-04 |
| Normal-vs-Age(61-80Yrs) |
3.3997999999702E-06 |
| Normal-vs-Age(81-100Yrs) |
3.514400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.434200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.171600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.246400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.050500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.963800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.701000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.196500E-03 |
| Classical-VS-Follicular |
5.940200E-01 |
| Classical-VS-Other |
3.828200E-01 |
| Classical-VS-Normal |
6.230200E-04 |
| Tall-VS-Follicular |
2.380000E-02 |
| Tall-VS-Other |
5.435000E-01 |
| Tall-VS-Normal |
3.02090000015021E-07 |
| Follicular-VS-Other |
3.529800E-01 |
| Follicular-VS-Normal |
1.040930E-03 |
| Other-VS-Normal |
1.336500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.236000E-04 |
| Normal-vs-N1 |
3.58219999996301E-06 |
| N0-vs-N1 |
4.701800E-02 |
|
|
